Amir Nashat

Amir Nashat

Direttore/Membro del Consiglio presso MORPHIC HOLDING, INC.

Patrimonio netto: 367 224 $ in data 31/05/2023

51 anni
Health Technology
Finance
Commercial Services

Profilo

Amir H.
Nashat
is the founder of Living Proof, Inc. (founded in 2004) and Alioth, Inc. (founded in 2018).
He held the title of Chief Executive Officer & Director at Living Proof, Inc. from 2004 to 2011.
Currently, he is the Chief Executive Officer & Director at Soufflé Therapeutics, Inc. and holds the position of Co-Chairman at Dewpoint Therapeutics, Inc. He is also the Chairman of Paratus Sciences Corp.
starting in 2024.
Additionally, he serves as a Director at TARIS BioMedical LLC, Partners Innovation Fund LLC, AgBiome INC, Scholar Rock, Inc., Freenome Holdings, Inc., Morphic Holding, Inc., Primmune Therapeutics, Inc., Institute For Protein Innovation, Inc., Aliothtalent, Kojin Therapeutics, Inc., Brain Games Corp., Camp4 Therapeutics Corp., Morphic Therapeutic, Inc., Matter Neuroscience, Inc., and Polaris Growth Management LLC.
Dr. Nashat has held former positions as the Chief Executive Officer of aTyr Pharma, Inc., Sun Catalytix Corp., Olivo Laboratories LLC, and Jnana Therapeutics, Inc. He was also the Chief Executive Officer & Director of Jnana Therapeutics, Inc. from 2017 to 2018.
He served as a Director at Athenix Corp., GI Dynamics, Inc., Pervasis Therapeutics, Inc., DNIB Unwind, Inc., CubicPV, Inc., Selecta Biosciences, Inc., Receptos LLC, KinDex Pharmaceuticals, Inc., Adnexus, Hydra Biosciences, Inc., WaveRx, Inc., Avila Therapeutics, Inc., New England Venture Capital Association, Inc., Fate Therapeutics, Inc., T2 Biosystems, Inc., L1 AgroSciences, Inc., Quintiles Biosciences, Inc., Syros Pharmaceuticals, Inc., Metacrine, Inc., Sofregen Medical, Inc., Pax Healthcare, Taris Holdings LLC, Promedior, Inc., Satellite Biosciences, Inc., and Scholar Rock Holding Corp.
Dr. Nashat obtained a doctorate degree from the Massachusetts Institute of Technology in 2002.
He also holds undergraduate and graduate degrees from the University of California, Berkeley, conferred in 1994 and 1996 respectively.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
09/05/2024 38 639 ( 0.05% ) 362 820 $ 31/05/2024
04/06/2024 145 ( 0.00% ) 4 404 $ 31/05/2024
03/02/2023 0 ( -.--% ) - $ 31/05/2023

Posizioni attive di Amir Nashat

SocietàPosizioneInizio
MORPHIC HOLDING, INC. Direttore/Membro del Consiglio 01/06/2017
Investitore di Private Equity 01/01/2002
Direttore/Membro del Consiglio 01/06/2017
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/01/2016
Presidente -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
Tutte le posizioni attive di Amir Nashat

Precedenti posizioni note di Amir Nashat

SocietàPosizioneFine
░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Amir Nashat

Formazione di Amir Nashat

Massachusetts Institute of Technology Doctorate Degree
University of California, Berkeley Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Amir Nashat

Relazioni

100 +

Relazioni di 1° grado

51

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa7
ATYR PHARMA, INC.

Health Technology

FATE THERAPEUTICS, INC.

Health Technology

T2 BIOSYSTEMS, INC.

Health Technology

SYROS PHARMACEUTICALS, INC.

Health Technology

MORPHIC HOLDING, INC.

Health Technology

SCHOLAR ROCK HOLDING CORPORATION

Health Technology

METACRINE, INC.

Health Technology

Aziende private42

Process Industries

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Finance

Producer Manufacturing

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Pax Healthcare

Aliothtalent

Health Technology

Health Technology

Brain Games Corp.

Technology Services

Health Technology

Taris Holdings LLC

Technology Services

Health Technology

Vedi le connessioni aziendali